Precigen Reports Second Quarter and First Half 2021 Financial Results
GERMANTOWN, Md., Aug. 9, 2021 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced second quarter and first half…
